GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1i3
|
ENSRNOG00000003260 | nuclear receptor subfamily 1, group I, member 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr1i3 | rn6_v1_chr13_+_89586283_89586336 | 0.30 | 7.2e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_78985990 | 97.32 |
ENSRNOT00000009248
|
Ambp
|
alpha-1-microglobulin/bikunin precursor |
chr8_+_116857684 | 74.29 |
ENSRNOT00000026711
|
Mst1
|
macrophage stimulating 1 |
chr19_+_52077109 | 73.64 |
ENSRNOT00000020225
|
Osgin1
|
oxidative stress induced growth inhibitor 1 |
chr12_-_11733099 | 64.78 |
ENSRNOT00000051244
ENSRNOT00000087257 |
Cyp3a23/3a1
|
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
chr2_-_182038178 | 63.71 |
ENSRNOT00000040708
|
Fgb
|
fibrinogen beta chain |
chr8_+_50525091 | 62.54 |
ENSRNOT00000074357
|
Apoa1
|
apolipoprotein A1 |
chr12_-_22194287 | 62.44 |
ENSRNOT00000082895
ENSRNOT00000001905 |
Tfr2
|
transferrin receptor 2 |
chr17_+_22620721 | 58.62 |
ENSRNOT00000019478
|
Adtrp
|
androgen-dependent TFPI-regulating protein |
chr20_-_12820466 | 58.58 |
ENSRNOT00000001699
|
Ftcd
|
formimidoyltransferase cyclodeaminase |
chr14_+_22724399 | 57.85 |
ENSRNOT00000002724
|
Ugt2b10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr8_-_85645718 | 57.84 |
ENSRNOT00000032185
|
Gsta2
|
glutathione S-transferase alpha 2 |
chr7_-_73270308 | 56.93 |
ENSRNOT00000007430
|
Rida
|
reactive intermediate imine deaminase A homolog |
chr20_+_28989491 | 56.73 |
ENSRNOT00000074524
|
Pla2g12b
|
phospholipase A2, group XIIB |
chr16_+_6970342 | 53.50 |
ENSRNOT00000061294
ENSRNOT00000048344 |
Itih4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr4_+_99063181 | 51.96 |
ENSRNOT00000008840
|
Fabp1
|
fatty acid binding protein 1 |
chr16_-_7007051 | 51.58 |
ENSRNOT00000023984
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr4_+_61850348 | 50.95 |
ENSRNOT00000013423
|
Akr1b7
|
aldo-keto reductase family 1, member B7 |
chr13_+_89597138 | 50.18 |
ENSRNOT00000004662
|
Apoa2
|
apolipoprotein A2 |
chr19_+_52077501 | 48.75 |
ENSRNOT00000079240
|
Osgin1
|
oxidative stress induced growth inhibitor 1 |
chr1_+_248723397 | 48.47 |
ENSRNOT00000072188
|
LOC100911854
|
mannose-binding protein C-like |
chr14_+_22375955 | 48.36 |
ENSRNOT00000063915
ENSRNOT00000034784 |
Ugt2b37
|
UDP-glucuronosyltransferase 2 family, member 37 |
chr17_+_22619891 | 48.32 |
ENSRNOT00000060403
|
Adtrp
|
androgen-dependent TFPI-regulating protein |
chr16_-_7007287 | 47.24 |
ENSRNOT00000041216
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr8_+_50537009 | 47.03 |
ENSRNOT00000080658
|
Apoa4
|
apolipoprotein A4 |
chr10_+_56662242 | 47.01 |
ENSRNOT00000086919
|
Asgr1
|
asialoglycoprotein receptor 1 |
chr5_-_19368431 | 46.70 |
ENSRNOT00000012819
|
Cyp7a1
|
cytochrome P450, family 7, subfamily a, polypeptide 1 |
chr11_+_65022100 | 46.23 |
ENSRNOT00000003934
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2 |
chr7_-_2677199 | 46.15 |
ENSRNOT00000043908
|
Apon
|
apolipoprotein N |
chr8_+_50559126 | 45.87 |
ENSRNOT00000024918
|
Apoa5
|
apolipoprotein A5 |
chr10_+_56662561 | 43.29 |
ENSRNOT00000025254
|
Asgr1
|
asialoglycoprotein receptor 1 |
chr1_-_170431073 | 42.78 |
ENSRNOT00000024710
|
Hpx
|
hemopexin |
chr7_-_102298522 | 42.71 |
ENSRNOT00000006273
|
A1bg
|
alpha-1-B glycoprotein |
chr4_-_30338679 | 42.38 |
ENSRNOT00000012050
|
Pon3
|
paraoxonase 3 |
chr8_-_77398156 | 42.34 |
ENSRNOT00000091858
ENSRNOT00000085349 ENSRNOT00000082763 |
Lipc
|
lipase C, hepatic type |
chr1_+_229030233 | 42.26 |
ENSRNOT00000084503
|
Glyatl1
|
glycine-N-acyltransferase-like 1 |
chr12_+_38828444 | 42.18 |
ENSRNOT00000001809
|
Hpd
|
4-hydroxyphenylpyruvate dioxygenase |
chr17_+_69468427 | 41.77 |
ENSRNOT00000058413
|
RGD1564865
|
similar to 20-alpha-hydroxysteroid dehydrogenase |
chr9_+_81968332 | 41.52 |
ENSRNOT00000023152
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1 |
chr18_+_70733872 | 41.35 |
ENSRNOT00000067018
|
Acaa2
|
acetyl-CoA acyltransferase 2 |
chr4_-_176679815 | 40.59 |
ENSRNOT00000090122
|
Gys2
|
glycogen synthase 2 |
chr13_-_56877611 | 40.50 |
ENSRNOT00000079040
ENSRNOT00000017195 |
Cfhr1
|
complement factor H-related 1 |
chr13_-_56693968 | 40.44 |
ENSRNOT00000060160
|
AABR07021096.1
|
|
chr1_-_76780230 | 40.25 |
ENSRNOT00000002046
|
LOC100912485
|
alcohol sulfotransferase-like |
chr5_+_134492756 | 40.24 |
ENSRNOT00000012888
ENSRNOT00000057095 ENSRNOT00000051385 |
Cyp4a1
|
cytochrome P450, family 4, subfamily a, polypeptide 1 |
chr12_+_10636275 | 38.73 |
ENSRNOT00000001285
|
Cyp3a18
|
cytochrome P450, family 3, subfamily a, polypeptide 18 |
chr19_+_15294248 | 38.39 |
ENSRNOT00000024622
|
Ces1f
|
carboxylesterase 1F |
chr19_+_50246402 | 37.92 |
ENSRNOT00000018795
|
Hsd17b2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
chr5_+_79179417 | 37.73 |
ENSRNOT00000010454
|
Orm1
|
orosomucoid 1 |
chr8_-_50531423 | 37.47 |
ENSRNOT00000090985
ENSRNOT00000074942 |
Apoc3
|
apolipoprotein C3 |
chr5_-_124403195 | 36.46 |
ENSRNOT00000067850
|
C8a
|
complement C8 alpha chain |
chr9_+_100281339 | 36.43 |
ENSRNOT00000029127
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr2_-_243407608 | 36.04 |
ENSRNOT00000014631
|
Mttp
|
microsomal triglyceride transfer protein |
chr1_+_189241593 | 35.66 |
ENSRNOT00000046025
|
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr12_+_9446940 | 35.17 |
ENSRNOT00000074791
|
Urad
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase |
chr5_+_124300477 | 34.98 |
ENSRNOT00000010100
|
C8b
|
complement C8 beta chain |
chr1_-_224533219 | 34.84 |
ENSRNOT00000051289
|
Ust5r
|
integral membrane transport protein UST5r |
chr16_-_81822716 | 34.02 |
ENSRNOT00000026677
|
F10
|
coagulation factor X |
chr2_+_60337667 | 33.50 |
ENSRNOT00000024035
|
Agxt2
|
alanine-glyoxylate aminotransferase 2 |
chr9_-_4945352 | 33.50 |
ENSRNOT00000082530
|
Sult1c3
|
sulfotransferase family 1C member 3 |
chr10_+_96639924 | 33.44 |
ENSRNOT00000004756
|
Apoh
|
apolipoprotein H |
chr7_-_123621102 | 33.35 |
ENSRNOT00000046024
|
Cyp2d5
|
cytochrome P450, family 2, subfamily d, polypeptide 5 |
chr10_-_46404642 | 32.79 |
ENSRNOT00000083698
|
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr3_-_127500709 | 32.72 |
ENSRNOT00000006330
|
Hao1
|
hydroxyacid oxidase 1 |
chr13_-_47397890 | 32.55 |
ENSRNOT00000005505
|
C4bpb
|
complement component 4 binding protein, beta |
chr5_-_134207847 | 32.43 |
ENSRNOT00000083686
ENSRNOT00000088209 ENSRNOT00000051252 |
Cyp4a2
|
cytochrome P450, family 4, subfamily a, polypeptide 2 |
chr10_+_64952119 | 32.40 |
ENSRNOT00000012154
|
Pipox
|
pipecolic acid and sarcosine oxidase |
chr10_+_14240219 | 32.20 |
ENSRNOT00000020233
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr2_+_147496229 | 32.12 |
ENSRNOT00000022105
|
Tm4sf4
|
transmembrane 4 L six family member 4 |
chr2_+_20857202 | 31.95 |
ENSRNOT00000078919
|
Acot12
|
acyl-CoA thioesterase 12 |
chr17_+_72160735 | 31.37 |
ENSRNOT00000038817
|
Itih2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
chrX_-_1848904 | 31.37 |
ENSRNOT00000010984
|
Rgn
|
regucalcin |
chr8_+_112594691 | 31.26 |
ENSRNOT00000038383
ENSRNOT00000081281 |
Acad11
|
acyl-CoA dehydrogenase family, member 11 |
chr1_+_16910069 | 30.99 |
ENSRNOT00000020015
|
Aldh8a1
|
aldehyde dehydrogenase 8 family, member A1 |
chr5_-_126911520 | 30.97 |
ENSRNOT00000091521
|
Dio1
|
deiodinase, iodothyronine, type I |
chr3_-_2727616 | 30.65 |
ENSRNOT00000061904
|
C8g
|
complement C8 gamma chain |
chr16_+_18690649 | 30.58 |
ENSRNOT00000015190
|
Mat1a
|
methionine adenosyltransferase 1A |
chr1_-_258875572 | 30.35 |
ENSRNOT00000093005
|
Cyp2c13
|
cytochrome P450, family 2, subfamily c, polypeptide 13 |
chr13_+_56598957 | 30.14 |
ENSRNOT00000016944
ENSRNOT00000080335 ENSRNOT00000089913 |
F13b
|
coagulation factor XIII B chain |
chr16_+_54164431 | 30.05 |
ENSRNOT00000090763
|
Fgl1
|
fibrinogen-like 1 |
chr1_+_107344904 | 29.81 |
ENSRNOT00000082582
|
Gas2
|
growth arrest-specific 2 |
chr10_-_62273119 | 29.77 |
ENSRNOT00000004322
|
Serpinf2
|
serpin family F member 2 |
chr7_-_78847974 | 29.33 |
ENSRNOT00000006004
|
Dpys
|
dihydropyrimidinase |
chr13_-_56763981 | 29.29 |
ENSRNOT00000087916
|
LOC100361907
|
complement factor H-related protein B |
chr1_+_282567674 | 29.17 |
ENSRNOT00000090543
|
Ces2i
|
carboxylesterase 2I |
chr9_+_95274707 | 28.95 |
ENSRNOT00000045163
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr6_+_56846789 | 28.95 |
ENSRNOT00000032108
|
Agmo
|
alkylglycerol monooxygenase |
chr1_-_259287684 | 28.78 |
ENSRNOT00000054724
|
Cyp2c22
|
cytochrome P450, family 2, subfamily c, polypeptide 22 |
chr1_+_213511874 | 28.50 |
ENSRNOT00000078080
ENSRNOT00000016883 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr1_-_89539210 | 28.29 |
ENSRNOT00000077462
ENSRNOT00000028644 |
Hpn
|
hepsin |
chr13_+_78805347 | 28.22 |
ENSRNOT00000003748
|
Serpinc1
|
serpin family C member 1 |
chr2_+_181987217 | 27.70 |
ENSRNOT00000034521
|
Fgg
|
fibrinogen gamma chain |
chr4_-_50200328 | 27.68 |
ENSRNOT00000060530
|
Aass
|
aminoadipate-semialdehyde synthase |
chr8_+_59507990 | 26.99 |
ENSRNOT00000018003
|
Hykk
|
hydroxylysine kinase |
chr14_+_22724070 | 26.72 |
ENSRNOT00000089471
|
Ugt2b10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr1_+_83653234 | 26.62 |
ENSRNOT00000085008
ENSRNOT00000084230 ENSRNOT00000090071 |
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1 |
chr9_+_100285804 | 26.24 |
ENSRNOT00000079305
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr9_+_95256627 | 26.19 |
ENSRNOT00000025291
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr17_+_76002275 | 26.12 |
ENSRNOT00000092665
ENSRNOT00000086701 |
Echdc3
|
enoyl CoA hydratase domain containing 3 |
chr17_-_43537293 | 25.94 |
ENSRNOT00000091749
|
Slc17a3
|
solute carrier family 17 member 3 |
chr9_+_16924520 | 25.84 |
ENSRNOT00000025094
|
Slc22a7
|
solute carrier family 22 member 7 |
chr11_-_87924816 | 25.80 |
ENSRNOT00000031819
|
Serpind1
|
serpin family D member 1 |
chr1_+_83933942 | 25.77 |
ENSRNOT00000068690
|
Cyp2f4
|
cytochrome P450, family 2, subfamily f, polypeptide 4 |
chr11_-_81444375 | 25.71 |
ENSRNOT00000058479
ENSRNOT00000078131 ENSRNOT00000080949 ENSRNOT00000080562 ENSRNOT00000084867 |
Kng1
|
kininogen 1 |
chr1_+_282568287 | 25.68 |
ENSRNOT00000015997
|
Ces2i
|
carboxylesterase 2I |
chr8_-_50539331 | 25.64 |
ENSRNOT00000088997
|
AABR07073400.1
|
|
chr5_-_134484839 | 25.51 |
ENSRNOT00000045571
ENSRNOT00000012681 |
Cyp4a2
|
cytochrome P450, family 4, subfamily a, polypeptide 2 |
chr17_-_417480 | 25.23 |
ENSRNOT00000023685
|
Fbp1
|
fructose-bisphosphatase 1 |
chr16_+_50179458 | 24.78 |
ENSRNOT00000041946
|
F11
|
coagulation factor XI |
chr16_-_81834945 | 24.30 |
ENSRNOT00000037806
|
F7
|
coagulation factor VII |
chr5_-_9429859 | 24.13 |
ENSRNOT00000009462
|
Adhfe1
|
alcohol dehydrogenase, iron containing, 1 |
chr6_+_127946686 | 24.06 |
ENSRNOT00000082680
|
LOC500712
|
Ab1-233 |
chr10_-_50402616 | 24.06 |
ENSRNOT00000004546
|
Hs3st3b1
|
heparan sulfate-glucosamine 3-sulfotransferase 3B1 |
chr12_+_19196611 | 23.92 |
ENSRNOT00000001801
|
Azgp1
|
alpha-2-glycoprotein 1, zinc-binding |
chr2_-_23256158 | 23.89 |
ENSRNOT00000015336
|
Bhmt
|
betaine-homocysteine S-methyltransferase |
chr10_+_56710965 | 23.82 |
ENSRNOT00000087121
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr4_-_115332052 | 23.53 |
ENSRNOT00000017643
|
Clec4f
|
C-type lectin domain family 4, member F |
chr9_-_19880346 | 23.06 |
ENSRNOT00000014051
|
Cyp39a1
|
cytochrome P450, family 39, subfamily a, polypeptide 1 |
chr15_+_57290849 | 23.01 |
ENSRNOT00000014909
|
Cpb2
|
carboxypeptidase B2 |
chr1_-_219312240 | 22.97 |
ENSRNOT00000066691
|
RGD1307603
|
similar to hypothetical protein MGC37914 |
chr1_-_76614279 | 22.86 |
ENSRNOT00000041367
ENSRNOT00000089371 |
LOC100912485
|
alcohol sulfotransferase-like |
chr5_+_160306727 | 22.86 |
ENSRNOT00000016648
|
Agmat
|
agmatinase |
chr13_-_47377703 | 22.84 |
ENSRNOT00000005461
|
C4bpa
|
complement component 4 binding protein, alpha |
chr18_-_40716686 | 22.82 |
ENSRNOT00000000172
|
Cdo1
|
cysteine dioxygenase type 1 |
chr1_-_164143818 | 22.68 |
ENSRNOT00000022557
|
Dgat2
|
diacylglycerol O-acyltransferase 2 |
chr2_+_54466280 | 22.65 |
ENSRNOT00000033112
|
C6
|
complement C6 |
chr1_-_80617057 | 22.63 |
ENSRNOT00000080453
|
Apoe
|
apolipoprotein E |
chr8_-_56393233 | 22.42 |
ENSRNOT00000016263
|
Fdx1
|
ferredoxin 1 |
chr7_+_71057911 | 22.42 |
ENSRNOT00000037218
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr4_+_109497962 | 22.23 |
ENSRNOT00000057869
|
Reg1a
|
regenerating family member 1 alpha |
chr3_-_55587946 | 21.97 |
ENSRNOT00000075107
|
Abcb11
|
ATP binding cassette subfamily B member 11 |
chr5_+_124476168 | 21.91 |
ENSRNOT00000077754
|
RGD1564074
|
similar to novel protein |
chr8_+_85553734 | 21.76 |
ENSRNOT00000044944
|
Gsta5
|
glutathione S-transferase alpha 5 |
chr6_-_104631355 | 21.65 |
ENSRNOT00000007825
|
Slc10a1
|
solute carrier family 10 member 1 |
chr8_+_115151627 | 21.60 |
ENSRNOT00000064252
|
Abhd14b
|
abhydrolase domain containing 14b |
chr6_+_80188943 | 21.49 |
ENSRNOT00000059335
|
Mia2
|
melanoma inhibitory activity 2 |
chr7_+_2605719 | 21.45 |
ENSRNOT00000018737
|
Gls2
|
glutaminase 2 |
chr5_-_59165160 | 21.45 |
ENSRNOT00000029035
|
Fam221b
|
family with sequence similarity 221, member B |
chr9_+_4269160 | 21.44 |
ENSRNOT00000050420
|
Sult1c2
|
sulfotransferase family 1C member 2 |
chr10_-_103848035 | 21.10 |
ENSRNOT00000029001
|
Fads6
|
fatty acid desaturase 6 |
chr17_+_56935451 | 21.04 |
ENSRNOT00000058966
|
RGD1564129
|
similar to hypothetical protein 4930474N05 |
chr2_-_236480502 | 20.87 |
ENSRNOT00000015020
|
Sgms2
|
sphingomyelin synthase 2 |
chr4_+_57855416 | 20.80 |
ENSRNOT00000029608
|
Cpa2
|
carboxypeptidase A2 |
chr5_-_160383782 | 20.53 |
ENSRNOT00000018349
|
Cela2a
|
chymotrypsin-like elastase family, member 2A |
chr9_+_27408333 | 20.49 |
ENSRNOT00000088416
|
Gsta3
|
glutathione S-transferase alpha 3 |
chr9_-_4327679 | 20.28 |
ENSRNOT00000073468
|
LOC100910235
|
sulfotransferase 1C1-like |
chr10_-_57653359 | 20.17 |
ENSRNOT00000089638
|
Derl2
|
derlin 2 |
chr1_-_219311502 | 20.16 |
ENSRNOT00000085439
|
RGD1307603
|
similar to hypothetical protein MGC37914 |
chr20_-_8202924 | 20.13 |
ENSRNOT00000071399
|
Tmem217
|
transmembrane protein 217 |
chr3_-_80012750 | 20.10 |
ENSRNOT00000018154
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3 |
chr4_-_70747226 | 20.03 |
ENSRNOT00000044960
|
LOC102554637
|
anionic trypsin-2-like |
chr5_-_78042556 | 19.86 |
ENSRNOT00000076005
|
Rn50_5_0819.1
|
|
chr4_+_163162211 | 19.77 |
ENSRNOT00000082537
|
Clec1b
|
C-type lectin domain family 1, member B |
chr4_+_57952982 | 19.74 |
ENSRNOT00000014465
|
Cpa1
|
carboxypeptidase A1 |
chr7_-_123655896 | 19.50 |
ENSRNOT00000012413
|
Cyp2d2
|
cytochrome P450, family 2, subfamily d, polypeptide 2 |
chr14_-_19072677 | 19.39 |
ENSRNOT00000060548
|
LOC360919
|
similar to alpha-fetoprotein |
chr9_+_9721105 | 19.34 |
ENSRNOT00000073042
ENSRNOT00000075494 |
C3
|
complement C3 |
chr4_+_71621729 | 19.20 |
ENSRNOT00000022275
|
Gstk1
|
glutathione S-transferase kappa 1 |
chr6_+_2216623 | 19.15 |
ENSRNOT00000008045
|
Rmdn2
|
regulator of microtubule dynamics 2 |
chr16_+_74865516 | 19.05 |
ENSRNOT00000058072
|
Atp7b
|
ATPase copper transporting beta |
chr4_+_100465170 | 19.05 |
ENSRNOT00000019571
|
Retsat
|
retinol saturase |
chr3_+_171213936 | 19.02 |
ENSRNOT00000031586
|
Pck1
|
phosphoenolpyruvate carboxykinase 1 |
chr11_+_74057361 | 18.91 |
ENSRNOT00000048746
|
Cpn2
|
carboxypeptidase N subunit 2 |
chr18_+_32964763 | 18.68 |
ENSRNOT00000019467
|
Pabpc2
|
poly(A) binding protein, cytoplasmic 2 |
chr1_-_84856309 | 18.66 |
ENSRNOT00000079567
|
AABR07002783.1
|
|
chr4_-_68349273 | 18.65 |
ENSRNOT00000016251
|
Prss37
|
protease, serine, 37 |
chr19_-_53477420 | 18.55 |
ENSRNOT00000071344
|
LOC687560
|
hypothetical protein LOC687560 |
chr13_+_91080341 | 18.39 |
ENSRNOT00000000058
|
Crp
|
C-reactive protein |
chr1_+_263554453 | 18.35 |
ENSRNOT00000070861
|
Abcc2
|
ATP binding cassette subfamily C member 2 |
chr1_+_48273611 | 18.26 |
ENSRNOT00000022254
ENSRNOT00000022068 |
Slc22a1
|
solute carrier family 22 member 1 |
chr11_-_72614176 | 18.21 |
ENSRNOT00000002366
|
Bdh1
|
3-hydroxybutyrate dehydrogenase 1 |
chr4_-_169036950 | 18.19 |
ENSRNOT00000011295
|
Gsg1
|
germ cell associated 1 |
chr8_+_71167305 | 18.19 |
ENSRNOT00000021337
|
Rbpms2
|
RNA binding protein with multiple splicing 2 |
chr3_+_54253949 | 18.17 |
ENSRNOT00000010018
|
B3galt1
|
Beta-1,3-galactosyltransferase 1 |
chr7_+_93975451 | 18.09 |
ENSRNOT00000011379
|
Colec10
|
collectin subfamily member 10 |
chr2_-_196113149 | 18.06 |
ENSRNOT00000088465
|
Selenbp1
|
selenium binding protein 1 |
chr4_+_174181644 | 18.04 |
ENSRNOT00000011555
|
Capza3
|
capping actin protein of muscle Z-line alpha subunit 3 |
chr9_-_26707571 | 17.97 |
ENSRNOT00000080948
|
AABR07067023.1
|
|
chr13_-_57080491 | 17.96 |
ENSRNOT00000017749
ENSRNOT00000086572 ENSRNOT00000060111 |
Cfh
|
complement factor H |
chr1_+_226234074 | 17.92 |
ENSRNOT00000027834
|
Fads1
|
fatty acid desaturase 1 |
chr1_-_22625204 | 17.92 |
ENSRNOT00000021694
|
Vnn1
|
vanin 1 |
chr19_+_15094309 | 17.83 |
ENSRNOT00000083500
|
Ces1f
|
carboxylesterase 1F |
chr4_-_22192474 | 17.80 |
ENSRNOT00000043822
|
Abcb1a
|
ATP binding cassette subfamily B member 1A |
chr14_-_89238094 | 17.64 |
ENSRNOT00000006818
|
Sun3
|
Sad1 and UNC84 domain containing 3 |
chr13_-_80819218 | 17.55 |
ENSRNOT00000072922
|
Fmo6
|
flavin containing monooxygenase 6 |
chr6_-_7961207 | 17.27 |
ENSRNOT00000007174
|
Abcg5
|
ATP binding cassette subfamily G member 5 |
chr1_-_224389389 | 17.16 |
ENSRNOT00000077408
ENSRNOT00000050010 |
UST4r
|
integral membrane transport protein UST4r |
chr10_-_104564480 | 17.12 |
ENSRNOT00000008525
|
Galk1
|
galactokinase 1 |
chr5_-_75116490 | 17.06 |
ENSRNOT00000042788
|
Txndc8
|
thioredoxin domain containing 8 |
chr17_+_76306585 | 16.95 |
ENSRNOT00000065978
|
Dhtkd1
|
dehydrogenase E1 and transketolase domain containing 1 |
chr5_-_134638150 | 16.92 |
ENSRNOT00000013480
|
Tex38
|
testis expressed 38 |
chr1_+_20856187 | 16.88 |
ENSRNOT00000071726
|
Smlr1
|
small leucine-rich protein 1 |
chr8_-_111721303 | 16.86 |
ENSRNOT00000045628
ENSRNOT00000012725 |
Tf
|
transferrin |
chr5_+_69833225 | 16.83 |
ENSRNOT00000013759
|
Nipsnap3b
|
nipsnap homolog 3B |
chr2_+_58462949 | 16.79 |
ENSRNOT00000080618
|
Nadk2
|
NAD kinase 2, mitochondrial |
chr7_-_117680004 | 16.73 |
ENSRNOT00000040422
|
Slc39a4
|
solute carrier family 39 member 4 |
chr4_-_77489535 | 16.67 |
ENSRNOT00000008728
|
Pdia4
|
protein disulfide isomerase family A, member 4 |
chr13_+_78812394 | 16.65 |
ENSRNOT00000076043
|
Serpinc1
|
serpin family C member 1 |
chr11_+_61609370 | 16.60 |
ENSRNOT00000088880
ENSRNOT00000082533 |
Gramd1c
|
GRAM domain containing 1C |
chr3_-_14229067 | 16.57 |
ENSRNOT00000025534
ENSRNOT00000092865 |
C5
|
complement C5 |
chr10_-_29450644 | 16.55 |
ENSRNOT00000087937
|
Adra1b
|
adrenoceptor alpha 1B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
50.1 | 150.2 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
45.9 | 45.9 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
32.1 | 96.2 | GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) |
27.1 | 108.6 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
24.3 | 24.3 | GO:1904612 | response to 2,3,7,8-tetrachlorodibenzodioxine(GO:1904612) |
20.8 | 62.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
19.8 | 79.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
19.7 | 59.0 | GO:0051977 | lysophospholipid transport(GO:0051977) |
19.6 | 78.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
19.5 | 58.6 | GO:0043606 | formate metabolic process(GO:0015942) histidine catabolic process to glutamate and formamide(GO:0019556) formamide metabolic process(GO:0043606) |
18.9 | 56.7 | GO:0010034 | response to acetate(GO:0010034) |
18.5 | 55.4 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
18.4 | 18.4 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
15.2 | 60.6 | GO:0019474 | lysine catabolic process(GO:0006554) L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
14.3 | 28.5 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
14.2 | 42.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
14.0 | 42.0 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
13.8 | 41.5 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
12.3 | 37.0 | GO:0002933 | lipid hydroxylation(GO:0002933) |
12.3 | 36.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
11.4 | 91.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
11.3 | 45.0 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
11.2 | 11.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
10.8 | 10.8 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
10.5 | 31.4 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
10.3 | 93.1 | GO:0046618 | drug export(GO:0046618) |
10.2 | 102.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
10.2 | 132.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
9.9 | 29.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
9.7 | 29.2 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
9.4 | 28.3 | GO:0034769 | basement membrane disassembly(GO:0034769) |
9.2 | 55.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
9.0 | 45.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
8.6 | 17.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
8.6 | 25.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
8.6 | 60.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
8.5 | 42.3 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
8.3 | 25.0 | GO:0042196 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
8.2 | 32.9 | GO:0009441 | glycolate metabolic process(GO:0009441) |
8.0 | 23.9 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
7.6 | 106.4 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
7.5 | 22.5 | GO:1904170 | phospholipid transfer to membrane(GO:0006649) NAD transport(GO:0043132) regulation of bleb assembly(GO:1904170) |
7.4 | 29.8 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
7.4 | 7.4 | GO:0042853 | L-alanine catabolic process(GO:0042853) |
7.4 | 51.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
7.3 | 29.3 | GO:0006212 | uracil catabolic process(GO:0006212) |
7.3 | 50.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
7.2 | 65.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
7.0 | 21.0 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
6.9 | 20.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
6.8 | 20.5 | GO:0046223 | toxin catabolic process(GO:0009407) mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) secondary metabolite catabolic process(GO:0090487) organic heteropentacyclic compound catabolic process(GO:1901377) |
6.7 | 60.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
6.7 | 26.6 | GO:0009804 | coumarin metabolic process(GO:0009804) |
6.6 | 85.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
6.5 | 64.8 | GO:0070989 | oxidative demethylation(GO:0070989) |
6.4 | 51.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
6.3 | 56.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
6.3 | 25.2 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
6.1 | 30.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
6.1 | 24.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
5.9 | 17.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
5.8 | 186.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
5.7 | 17.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
5.6 | 16.7 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
5.6 | 16.7 | GO:1904721 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
5.5 | 16.6 | GO:0045819 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) positive regulation of glycogen catabolic process(GO:0045819) |
5.5 | 21.8 | GO:0006565 | L-serine catabolic process(GO:0006565) |
5.4 | 16.2 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
5.3 | 10.7 | GO:0006710 | androgen catabolic process(GO:0006710) |
5.3 | 15.9 | GO:1990743 | protein sialylation(GO:1990743) |
5.3 | 47.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
5.2 | 25.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
5.2 | 10.3 | GO:0009751 | response to salicylic acid(GO:0009751) |
5.1 | 15.2 | GO:0008592 | regulation of Toll signaling pathway(GO:0008592) negative regulation of Toll signaling pathway(GO:0045751) |
5.0 | 15.1 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
5.0 | 35.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
4.9 | 14.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
4.9 | 43.8 | GO:0015747 | urate transport(GO:0015747) |
4.9 | 48.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
4.8 | 14.3 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
4.6 | 4.6 | GO:1904054 | regulation of cholangiocyte proliferation(GO:1904054) positive regulation of cholangiocyte proliferation(GO:1904056) |
4.5 | 22.7 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
4.5 | 63.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
4.5 | 17.9 | GO:0035565 | regulation of pronephros size(GO:0035565) |
4.4 | 22.0 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
4.4 | 13.1 | GO:0060166 | olfactory pit development(GO:0060166) |
4.4 | 13.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
4.2 | 21.2 | GO:0015793 | glycerol transport(GO:0015793) |
4.2 | 12.6 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
4.1 | 57.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
4.1 | 8.2 | GO:0016487 | sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
4.1 | 32.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
4.0 | 12.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
4.0 | 40.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
4.0 | 12.0 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) positive regulation of polyamine transmembrane transport(GO:1902269) |
4.0 | 71.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
3.9 | 27.6 | GO:0006477 | protein sulfation(GO:0006477) |
3.9 | 15.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
3.9 | 7.8 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
3.9 | 27.4 | GO:0006569 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
3.9 | 89.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
3.8 | 7.6 | GO:0030638 | polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
3.8 | 11.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
3.8 | 3.8 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
3.7 | 22.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
3.7 | 22.3 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
3.7 | 18.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.6 | 14.5 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
3.5 | 24.8 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
3.5 | 21.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
3.5 | 10.5 | GO:1905204 | septum secundum development(GO:0003285) embryonic heart tube anterior/posterior pattern specification(GO:0035054) negative regulation of connective tissue replacement(GO:1905204) |
3.5 | 13.8 | GO:1902861 | copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
3.4 | 10.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
3.4 | 10.3 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
3.4 | 10.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
3.4 | 6.7 | GO:2000426 | negative regulation of apoptotic cell clearance(GO:2000426) |
3.3 | 13.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
3.3 | 9.9 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
3.3 | 16.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
3.2 | 9.7 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
3.1 | 12.5 | GO:0001582 | detection of chemical stimulus involved in sensory perception of sweet taste(GO:0001582) |
3.1 | 18.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
3.1 | 3.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
3.0 | 9.1 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
3.0 | 8.9 | GO:0044209 | purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) AMP salvage(GO:0044209) adenosine biosynthetic process(GO:0046086) |
2.9 | 11.7 | GO:1990375 | baculum development(GO:1990375) |
2.9 | 8.7 | GO:0006574 | valine catabolic process(GO:0006574) |
2.9 | 77.1 | GO:0019835 | cytolysis(GO:0019835) |
2.8 | 14.2 | GO:0018158 | protein oxidation(GO:0018158) |
2.8 | 14.1 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
2.8 | 19.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
2.8 | 11.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
2.8 | 2.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
2.8 | 11.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.8 | 11.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
2.8 | 5.5 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
2.8 | 35.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
2.7 | 13.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
2.7 | 5.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
2.7 | 10.7 | GO:0015879 | carnitine transport(GO:0015879) |
2.7 | 2.7 | GO:0030647 | aminoglycoside antibiotic metabolic process(GO:0030647) |
2.7 | 8.0 | GO:0048861 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
2.7 | 18.6 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
2.6 | 26.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
2.6 | 13.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
2.6 | 29.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
2.6 | 10.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
2.5 | 10.2 | GO:1902896 | terminal web assembly(GO:1902896) |
2.5 | 12.3 | GO:0070541 | response to platinum ion(GO:0070541) |
2.5 | 14.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
2.4 | 44.0 | GO:0001675 | acrosome assembly(GO:0001675) |
2.4 | 12.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.4 | 16.8 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
2.4 | 7.2 | GO:0009249 | protein lipoylation(GO:0009249) |
2.4 | 14.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
2.4 | 4.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.4 | 2.4 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
2.4 | 7.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
2.3 | 7.0 | GO:0002462 | tolerance induction to nonself antigen(GO:0002462) |
2.3 | 7.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
2.3 | 13.9 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
2.3 | 9.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
2.2 | 18.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
2.2 | 6.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.2 | 11.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
2.2 | 6.6 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
2.2 | 6.6 | GO:0032258 | CVT pathway(GO:0032258) |
2.2 | 2.2 | GO:0071217 | cellular response to external biotic stimulus(GO:0071217) |
2.2 | 19.4 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
2.1 | 12.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
2.0 | 2.0 | GO:0030221 | basophil differentiation(GO:0030221) |
2.0 | 6.1 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
2.0 | 18.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
2.0 | 24.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
2.0 | 3.9 | GO:0072181 | mesonephric duct formation(GO:0072181) |
2.0 | 7.8 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.9 | 3.9 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
1.9 | 5.8 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
1.9 | 9.7 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.9 | 9.6 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.9 | 17.0 | GO:0051132 | NK T cell activation(GO:0051132) |
1.9 | 32.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.9 | 31.8 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
1.9 | 7.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.8 | 24.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.8 | 20.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.8 | 5.5 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
1.8 | 5.5 | GO:0010041 | response to iron(III) ion(GO:0010041) |
1.8 | 7.3 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
1.8 | 1.8 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.8 | 7.2 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.8 | 39.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
1.8 | 12.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.8 | 8.9 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
1.8 | 5.3 | GO:0061741 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
1.8 | 49.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
1.7 | 10.5 | GO:2000667 | positive regulation of interleukin-13 secretion(GO:2000667) |
1.7 | 5.2 | GO:0048749 | compound eye development(GO:0048749) |
1.7 | 20.6 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
1.7 | 10.3 | GO:0034756 | regulation of iron ion transport(GO:0034756) negative regulation of iron ion transport(GO:0034757) |
1.7 | 8.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
1.7 | 6.8 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
1.7 | 15.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
1.7 | 6.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.7 | 6.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.7 | 14.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.7 | 29.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.6 | 6.5 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
1.6 | 1.6 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
1.6 | 9.7 | GO:0015677 | copper ion import(GO:0015677) |
1.6 | 8.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
1.6 | 24.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
1.6 | 12.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.6 | 7.8 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.5 | 3.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.5 | 7.7 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
1.5 | 9.2 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) |
1.5 | 7.7 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.5 | 3.1 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
1.5 | 18.2 | GO:0050892 | intestinal absorption(GO:0050892) |
1.5 | 1.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.5 | 16.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
1.5 | 6.0 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.5 | 11.8 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
1.5 | 13.2 | GO:0051026 | chiasma assembly(GO:0051026) |
1.5 | 2.9 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.4 | 5.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.4 | 4.3 | GO:1901367 | response to L-cysteine(GO:1901367) |
1.4 | 4.2 | GO:1902996 | regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.4 | 7.1 | GO:0060005 | vestibular reflex(GO:0060005) |
1.4 | 2.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.4 | 12.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.4 | 5.5 | GO:0002084 | protein depalmitoylation(GO:0002084) |
1.4 | 6.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.4 | 35.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
1.4 | 6.8 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
1.4 | 4.1 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
1.4 | 49.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
1.4 | 20.4 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
1.4 | 10.8 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.3 | 2.7 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
1.3 | 4.0 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
1.3 | 4.0 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
1.3 | 6.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
1.3 | 31.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
1.3 | 3.9 | GO:0021539 | subthalamus development(GO:0021539) |
1.3 | 9.1 | GO:0042737 | drug catabolic process(GO:0042737) |
1.3 | 30.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
1.3 | 2.6 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
1.3 | 16.9 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
1.3 | 1.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.3 | 3.9 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) N-acetylneuraminate biosynthetic process(GO:0046380) glucosamine-containing compound biosynthetic process(GO:1901073) |
1.3 | 6.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.3 | 5.0 | GO:0071724 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
1.3 | 7.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.2 | 2.5 | GO:0036023 | embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.2 | 2.5 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
1.2 | 4.9 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.2 | 13.5 | GO:0006544 | glycine metabolic process(GO:0006544) |
1.2 | 25.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
1.2 | 4.9 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
1.2 | 7.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
1.2 | 4.8 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.2 | 21.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.2 | 4.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
1.2 | 3.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.2 | 5.9 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
1.2 | 33.8 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
1.2 | 4.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.2 | 2.3 | GO:1902219 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.2 | 10.4 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
1.1 | 2.3 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.1 | 5.7 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
1.1 | 3.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
1.1 | 17.0 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
1.1 | 7.8 | GO:0006706 | steroid catabolic process(GO:0006706) |
1.1 | 3.3 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
1.1 | 2.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
1.1 | 6.6 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
1.1 | 4.4 | GO:0070873 | regulation of polysaccharide metabolic process(GO:0032881) regulation of glycogen metabolic process(GO:0070873) |
1.1 | 5.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.1 | 8.8 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
1.1 | 24.1 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
1.1 | 4.3 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
1.1 | 6.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
1.1 | 3.2 | GO:1904956 | regulation of endodermal cell fate specification(GO:0042663) regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.1 | 8.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.1 | 18.0 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
1.0 | 1.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.0 | 5.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
1.0 | 2.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.0 | 5.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
1.0 | 4.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
1.0 | 8.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.0 | 2.0 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
1.0 | 3.0 | GO:0002396 | MHC protein complex assembly(GO:0002396) MHC class II protein complex assembly(GO:0002399) peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
1.0 | 11.0 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
1.0 | 13.8 | GO:0070633 | transepithelial transport(GO:0070633) |
1.0 | 3.9 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
1.0 | 7.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.0 | 3.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
1.0 | 2.9 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
1.0 | 6.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
1.0 | 8.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.0 | 3.8 | GO:0009642 | response to light intensity(GO:0009642) |
1.0 | 13.3 | GO:0045056 | transcytosis(GO:0045056) |
1.0 | 3.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.9 | 14.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.9 | 2.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.9 | 2.8 | GO:0046051 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) guanosine-containing compound biosynthetic process(GO:1901070) |
0.9 | 4.6 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.9 | 1.8 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.9 | 3.6 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.9 | 2.7 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.9 | 6.2 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.9 | 2.7 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.9 | 4.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.9 | 3.5 | GO:1901908 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.9 | 4.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.9 | 1.7 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.8 | 3.4 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.8 | 19.3 | GO:0042311 | vasodilation(GO:0042311) |
0.8 | 8.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.8 | 3.3 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.8 | 2.5 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.8 | 2.5 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.8 | 25.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.8 | 10.7 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.8 | 2.5 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.8 | 0.8 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.8 | 1.6 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
0.8 | 3.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.8 | 2.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.8 | 3.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.8 | 2.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.8 | 4.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.8 | 1.6 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.8 | 4.0 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.8 | 8.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.8 | 6.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.8 | 70.3 | GO:0007586 | digestion(GO:0007586) |
0.8 | 7.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.8 | 13.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.8 | 3.8 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.8 | 2.3 | GO:0032978 | protein insertion into membrane from inner side(GO:0032978) |
0.8 | 2.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.8 | 2.3 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.7 | 2.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.7 | 4.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.7 | 2.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.7 | 5.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.7 | 7.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.7 | 3.7 | GO:0001757 | somite specification(GO:0001757) |
0.7 | 2.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.7 | 0.7 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.7 | 18.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.7 | 4.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.7 | 2.2 | GO:1990790 | response to glial cell derived neurotrophic factor(GO:1990790) cellular response to glial cell derived neurotrophic factor(GO:1990792) |
0.7 | 7.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.7 | 1.4 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.7 | 2.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.7 | 1.4 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.7 | 7.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.7 | 2.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.7 | 17.4 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.7 | 2.8 | GO:0009624 | response to nematode(GO:0009624) |
0.7 | 1.4 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.7 | 2.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.7 | 2.1 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
0.7 | 2.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.7 | 2.7 | GO:0051958 | methotrexate transport(GO:0051958) |
0.7 | 7.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.7 | 5.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.7 | 1.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.7 | 0.7 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.7 | 3.4 | GO:0002001 | renin secretion into blood stream(GO:0002001) |
0.7 | 7.4 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.7 | 5.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.7 | 12.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.7 | 4.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.7 | 4.0 | GO:0015886 | heme transport(GO:0015886) |
0.6 | 1.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.6 | 1.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 3.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.6 | 4.5 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.6 | 1.3 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.6 | 15.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.6 | 1.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.6 | 3.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.6 | 5.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.6 | 3.7 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.6 | 9.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.6 | 1.8 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.6 | 2.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.6 | 1.8 | GO:1904640 | response to methionine(GO:1904640) |
0.6 | 2.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.6 | 1.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 4.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.6 | 13.4 | GO:0030220 | platelet formation(GO:0030220) |
0.6 | 1.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.6 | 2.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.6 | 1.7 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.6 | 2.3 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.6 | 2.3 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.6 | 7.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.6 | 1.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.6 | 5.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.6 | 5.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.6 | 5.6 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.6 | 1.1 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.6 | 3.9 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.5 | 1.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.5 | 6.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.5 | 3.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.5 | 4.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.5 | 7.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 3.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.5 | 0.5 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.5 | 15.7 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.5 | 1.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.5 | 3.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.5 | 5.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.5 | 5.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.5 | 6.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.5 | 6.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.5 | 1.6 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.5 | 7.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.5 | 1.5 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 6.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.5 | 2.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.5 | 2.0 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.5 | 5.6 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.5 | 8.6 | GO:0043486 | histone exchange(GO:0043486) |
0.5 | 1.5 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.5 | 4.4 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.5 | 3.4 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.5 | 2.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 1.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 1.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.5 | 14.1 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.5 | 13.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.5 | 5.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.5 | 4.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.5 | 3.7 | GO:0009650 | UV protection(GO:0009650) |
0.5 | 4.6 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.5 | 4.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.5 | 3.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.5 | 0.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 239.6 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.4 | 4.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 3.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.4 | 1.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 0.9 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.4 | 1.3 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.4 | 7.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.4 | 1.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 4.8 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.4 | 8.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 0.9 | GO:0097187 | dentinogenesis(GO:0097187) |
0.4 | 8.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.4 | 3.8 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 7.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.4 | 1.2 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.4 | 0.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.4 | 5.3 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.4 | 2.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.4 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 2.7 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 | 8.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.4 | 4.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.4 | 1.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 1.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 1.5 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.4 | 1.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 4.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.4 | 6.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.4 | 6.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.4 | 4.0 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.4 | 6.8 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.4 | 1.4 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.4 | 2.5 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.3 | 2.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.3 | 4.5 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.3 | 4.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 5.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.0 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.3 | 1.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 1.3 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 1.0 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 38.5 | GO:0007286 | spermatid development(GO:0007286) |
0.3 | 1.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 3.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 3.6 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 1.5 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.3 | 7.7 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.3 | 0.6 | GO:2000424 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
0.3 | 2.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.3 | 3.8 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 3.7 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 2.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.3 | 2.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.3 | 1.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 1.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.3 | 3.5 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.3 | 8.2 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.3 | 3.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 1.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 6.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 1.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 9.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.3 | 4.0 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 0.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.2 | 1.2 | GO:0045617 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.7 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.2 | 1.4 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.2 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
0.2 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.5 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 1.6 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.9 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.2 | 6.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 1.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 3.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 2.0 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.2 | 3.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.2 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 2.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.2 | 0.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 4.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 1.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 2.6 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.8 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 1.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 8.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 2.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 2.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.2 | 0.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.2 | 0.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 1.6 | GO:0019363 | nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
0.2 | 3.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 2.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 2.7 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.9 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.2 | 5.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.5 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.1 | 1.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 4.8 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 5.4 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.5 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.1 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 1.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 160.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.5 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 1.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) G2 DNA damage checkpoint(GO:0031572) |
0.1 | 2.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 1.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 3.7 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 1.4 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.3 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 1.3 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 1.9 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.1 | 0.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.4 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.1 | 0.2 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.1 | 0.5 | GO:1904117 | cellular response to vasopressin(GO:1904117) |
0.1 | 2.0 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 1.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.2 | GO:0060816 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 1.4 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 2.8 | GO:0034502 | protein localization to chromosome(GO:0034502) |
0.1 | 1.0 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 1.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.2 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.1 | 1.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.5 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.1 | GO:0021571 | rhombomere 3 development(GO:0021569) rhombomere 5 development(GO:0021571) |
0.0 | 0.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.6 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.0 | 0.5 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.0 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.0 | 0.4 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.6 | 306.2 | GO:0042627 | chylomicron(GO:0042627) |
15.3 | 107.4 | GO:0005579 | membrane attack complex(GO:0005579) |
15.1 | 121.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
13.2 | 79.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
11.7 | 58.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
8.2 | 82.4 | GO:0045179 | apical cortex(GO:0045179) |
8.0 | 24.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
6.9 | 34.4 | GO:0043159 | acrosomal matrix(GO:0043159) |
5.8 | 75.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
5.8 | 17.4 | GO:0045203 | intrinsic component of cell outer membrane(GO:0031230) integral component of cell outer membrane(GO:0045203) |
5.4 | 32.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
4.6 | 13.8 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) fumarate reductase complex(GO:0045283) |
4.5 | 85.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
4.4 | 506.4 | GO:0072562 | blood microparticle(GO:0072562) |
4.4 | 17.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
4.4 | 13.1 | GO:0000802 | transverse filament(GO:0000802) |
4.2 | 20.8 | GO:0097413 | Lewy body(GO:0097413) |
3.9 | 19.6 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
3.9 | 11.6 | GO:0031308 | intrinsic component of nuclear outer membrane(GO:0031308) integral component of nuclear outer membrane(GO:0031309) |
3.6 | 10.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
3.4 | 20.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
3.2 | 9.6 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
3.1 | 12.2 | GO:1990005 | granular vesicle(GO:1990005) |
3.0 | 20.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
3.0 | 26.7 | GO:0071546 | pi-body(GO:0071546) |
2.9 | 11.4 | GO:0030478 | actin cap(GO:0030478) |
2.7 | 10.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
2.7 | 8.1 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
2.7 | 40.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.6 | 51.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
2.5 | 22.5 | GO:0032059 | bleb(GO:0032059) |
2.5 | 35.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
2.5 | 12.5 | GO:1903768 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
2.4 | 7.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
2.4 | 7.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
2.2 | 6.7 | GO:0043511 | inhibin complex(GO:0043511) |
2.2 | 6.6 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
2.2 | 6.6 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
2.2 | 13.0 | GO:1990357 | terminal web(GO:1990357) |
2.0 | 18.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
1.9 | 21.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.9 | 5.6 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
1.7 | 262.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.7 | 15.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.7 | 236.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
1.6 | 19.8 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
1.6 | 8.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.6 | 6.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.6 | 25.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.5 | 15.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
1.5 | 43.8 | GO:0042588 | zymogen granule(GO:0042588) |
1.5 | 7.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.4 | 26.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.4 | 6.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.4 | 4.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.3 | 32.2 | GO:0031528 | microvillus membrane(GO:0031528) |
1.3 | 7.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
1.3 | 6.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.2 | 68.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.2 | 4.8 | GO:0018444 | translation release factor complex(GO:0018444) |
1.2 | 3.6 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
1.2 | 11.8 | GO:0042587 | glycogen granule(GO:0042587) |
1.2 | 19.9 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
1.1 | 19.4 | GO:0001520 | outer dense fiber(GO:0001520) |
1.1 | 840.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
1.1 | 7.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.1 | 19.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.1 | 24.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.1 | 4.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.1 | 3.2 | GO:0070421 | DNA ligase III-XRCC1 complex(GO:0070421) |
1.1 | 50.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.0 | 11.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.0 | 3.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
1.0 | 5.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.0 | 3.9 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
1.0 | 6.7 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.9 | 233.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.8 | 2.5 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.8 | 25.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.8 | 19.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.8 | 11.4 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 3.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.7 | 8.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.7 | 4.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.7 | 3.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.7 | 5.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 9.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.6 | 1.9 | GO:0005745 | m-AAA complex(GO:0005745) |
0.6 | 3.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.6 | 2.5 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.6 | 1.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 2.4 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.6 | 7.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 3.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.6 | 3.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.6 | 1.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 4.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 7.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.5 | 4.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.5 | 2.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.5 | 27.1 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 5.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.5 | 4.6 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.5 | 2.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 2.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.5 | 13.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.5 | 5.8 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.5 | 1.9 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.4 | 2.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 1.3 | GO:0060187 | cell pole(GO:0060187) |
0.4 | 8.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 2.1 | GO:0045009 | melanosome membrane(GO:0033162) ER-mitochondrion membrane contact site(GO:0044233) chitosome(GO:0045009) |
0.4 | 2.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 6.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.4 | 3.4 | GO:0002177 | manchette(GO:0002177) |
0.4 | 3.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 3.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 2.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.4 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.3 | 6.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 2.4 | GO:0036449 | zonula adherens(GO:0005915) microtubule minus-end(GO:0036449) |
0.3 | 2.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 2.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 2.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 6.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 23.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 4.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 21.6 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 5.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 23.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.3 | 0.8 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 8.1 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.3 | 4.4 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 1.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 1.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 2.3 | GO:0070187 | telosome(GO:0070187) |
0.3 | 4.1 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 3.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 4.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 0.8 | GO:0044307 | dendritic branch(GO:0044307) |
0.3 | 2.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 3.2 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 1.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 7.4 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 3.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 1.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 1.2 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 63.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 197.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 1.6 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 3.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 2.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 3.8 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 2.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 2.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 4.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 2.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 1.0 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 2.8 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 5.7 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 1.4 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.5 | GO:0031597 | nuclear proteasome complex(GO:0031595) cytosolic proteasome complex(GO:0031597) |
0.1 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.8 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.3 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 62.1 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
50.1 | 150.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
26.4 | 79.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
24.5 | 98.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
19.5 | 97.3 | GO:0019862 | IgA binding(GO:0019862) |
19.2 | 96.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
17.4 | 69.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
16.1 | 80.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
14.1 | 42.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
12.7 | 38.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
12.0 | 35.9 | GO:0031714 | C5a anaphylatoxin chemotactic receptor binding(GO:0031714) |
11.4 | 68.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
11.4 | 319.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
10.6 | 74.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
10.2 | 30.6 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
9.7 | 58.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
9.6 | 38.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
9.4 | 37.5 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
8.9 | 26.8 | GO:0015203 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
8.9 | 35.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
8.8 | 35.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
8.8 | 26.4 | GO:0032810 | sterol response element binding(GO:0032810) |
8.4 | 33.5 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
8.3 | 24.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
8.2 | 32.7 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) |
8.1 | 40.7 | GO:0005534 | galactose binding(GO:0005534) |
8.0 | 32.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
7.8 | 62.3 | GO:0008430 | selenium binding(GO:0008430) |
7.7 | 23.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
7.3 | 29.3 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
7.2 | 36.1 | GO:0070404 | NADH binding(GO:0070404) |
7.2 | 136.1 | GO:0001848 | complement binding(GO:0001848) |
7.2 | 21.5 | GO:0004359 | glutaminase activity(GO:0004359) |
7.0 | 21.0 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
6.9 | 20.6 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
6.7 | 66.9 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
6.7 | 13.4 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
6.5 | 52.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
6.5 | 58.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
6.5 | 25.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
6.3 | 38.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
6.3 | 69.6 | GO:0039706 | co-receptor binding(GO:0039706) |
6.3 | 125.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
6.3 | 194.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
6.0 | 24.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
6.0 | 24.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
5.8 | 29.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
5.8 | 40.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
5.8 | 51.9 | GO:0015232 | heme transporter activity(GO:0015232) |
5.7 | 34.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
5.7 | 17.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
5.6 | 33.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
5.6 | 28.1 | GO:0005550 | pheromone binding(GO:0005550) |
5.5 | 44.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
5.5 | 21.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
5.4 | 37.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
5.2 | 51.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
4.9 | 19.6 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
4.8 | 14.3 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
4.6 | 13.8 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
4.6 | 36.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
4.5 | 18.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
4.5 | 27.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
4.4 | 97.0 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
4.4 | 22.0 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
4.3 | 13.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
4.3 | 13.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
4.3 | 168.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
4.2 | 38.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
4.2 | 16.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
4.1 | 12.3 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
4.1 | 20.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
4.0 | 40.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
4.0 | 24.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
4.0 | 12.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
3.9 | 19.6 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
3.9 | 27.1 | GO:0032052 | bile acid binding(GO:0032052) |
3.8 | 15.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
3.7 | 14.8 | GO:0008265 | Mo-molybdopterin cofactor sulfurase activity(GO:0008265) |
3.7 | 11.0 | GO:2001070 | starch binding(GO:2001070) |
3.6 | 14.5 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
3.6 | 10.8 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
3.5 | 10.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
3.5 | 41.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
3.5 | 20.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
3.4 | 10.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
3.3 | 40.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
3.3 | 9.9 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
3.3 | 22.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
3.2 | 9.7 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
3.2 | 25.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
3.2 | 25.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.1 | 12.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
3.1 | 12.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
3.1 | 12.5 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
3.0 | 18.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
3.0 | 24.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
3.0 | 342.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
3.0 | 11.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.9 | 8.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
2.8 | 16.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
2.7 | 22.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
2.7 | 5.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.7 | 8.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.6 | 5.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
2.6 | 13.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.6 | 7.8 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
2.6 | 33.6 | GO:0016208 | AMP binding(GO:0016208) |
2.6 | 20.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
2.6 | 33.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
2.5 | 15.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.5 | 94.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
2.5 | 59.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
2.5 | 7.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
2.5 | 7.4 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
2.4 | 12.1 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
2.4 | 21.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
2.3 | 44.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
2.3 | 11.7 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
2.3 | 9.1 | GO:0034584 | piRNA binding(GO:0034584) |
2.3 | 9.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
2.2 | 6.7 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
2.2 | 22.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
2.2 | 66.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
2.2 | 13.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
2.2 | 8.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
2.2 | 8.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
2.1 | 14.6 | GO:0035375 | zymogen binding(GO:0035375) |
2.0 | 22.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
2.0 | 11.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.9 | 13.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.8 | 27.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.8 | 7.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.8 | 14.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.8 | 372.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.7 | 8.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.7 | 5.2 | GO:0030977 | taurine binding(GO:0030977) |
1.7 | 5.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
1.7 | 6.7 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
1.6 | 40.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.6 | 9.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.6 | 6.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.6 | 6.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.6 | 20.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.6 | 3.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.6 | 15.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.5 | 7.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.5 | 9.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.5 | 12.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.5 | 4.6 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
1.4 | 4.3 | GO:0003922 | GMP synthase activity(GO:0003921) GMP synthase (glutamine-hydrolyzing) activity(GO:0003922) |
1.4 | 5.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
1.4 | 8.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.4 | 8.6 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
1.4 | 7.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.4 | 19.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.4 | 7.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.4 | 8.5 | GO:0031404 | chloride ion binding(GO:0031404) |
1.4 | 7.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.4 | 5.6 | GO:0042731 | PH domain binding(GO:0042731) |
1.4 | 4.2 | GO:0047708 | biotinidase activity(GO:0047708) |
1.4 | 11.0 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.4 | 6.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.4 | 8.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.4 | 6.9 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.4 | 4.1 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
1.4 | 67.9 | GO:0038024 | cargo receptor activity(GO:0038024) |
1.4 | 4.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.3 | 4.0 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
1.3 | 34.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.3 | 10.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.3 | 14.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.3 | 9.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.3 | 3.9 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
1.3 | 5.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.3 | 6.3 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.3 | 5.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.3 | 7.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.3 | 21.3 | GO:0005537 | mannose binding(GO:0005537) |
1.2 | 5.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
1.2 | 8.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.2 | 8.6 | GO:0034711 | inhibin binding(GO:0034711) |
1.2 | 10.8 | GO:0060229 | lipase activator activity(GO:0060229) |
1.2 | 4.8 | GO:0000829 | inositol heptakisphosphate kinase activity(GO:0000829) |
1.2 | 3.6 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.2 | 4.7 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
1.1 | 11.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.1 | 7.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.1 | 14.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
1.1 | 6.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.1 | 28.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.1 | 5.3 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
1.1 | 8.5 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
1.1 | 5.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.0 | 5.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
1.0 | 4.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.0 | 3.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.0 | 5.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
1.0 | 4.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
1.0 | 3.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.0 | 3.0 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.0 | 14.8 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.0 | 102.0 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.9 | 3.8 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.9 | 3.8 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.9 | 2.8 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.9 | 2.7 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.9 | 2.7 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.9 | 2.7 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.9 | 3.5 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.9 | 3.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.9 | 4.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.9 | 3.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.8 | 67.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.8 | 6.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.8 | 11.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.8 | 3.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.8 | 2.4 | GO:0017042 | glycosylceramidase activity(GO:0017042) |
0.8 | 13.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.8 | 2.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.8 | 9.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.8 | 6.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.8 | 16.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.7 | 8.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.7 | 2.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.7 | 2.1 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.7 | 2.7 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.7 | 9.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 7.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.7 | 51.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.7 | 2.0 | GO:0031765 | galanin receptor binding(GO:0031763) type 2 galanin receptor binding(GO:0031765) type 3 galanin receptor binding(GO:0031766) |
0.7 | 16.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.7 | 6.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.7 | 3.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.7 | 2.0 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.6 | 5.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 8.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.6 | 5.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.6 | 5.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.6 | 3.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.6 | 98.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.6 | 11.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 5.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.6 | 6.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.6 | 3.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.6 | 3.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 1.2 | GO:0042806 | fucose binding(GO:0042806) |
0.6 | 9.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.6 | 4.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.6 | 15.7 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.6 | 2.3 | GO:0043295 | glutathione binding(GO:0043295) |
0.6 | 5.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.6 | 5.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.5 | 2.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 4.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.5 | 2.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.5 | 2.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.5 | 12.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.5 | 2.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.5 | 7.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 1.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 1.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.5 | 2.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 4.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 2.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 1.4 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.5 | 5.9 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.4 | 4.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 1.3 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.4 | 3.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 1.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.4 | 6.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 4.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 11.1 | GO:0070001 | aspartic-type peptidase activity(GO:0070001) |
0.4 | 4.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 1.7 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.4 | 4.6 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 1.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.4 | 6.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 4.0 | GO:0015926 | glucosidase activity(GO:0015926) |
0.4 | 2.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 3.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.4 | 1.5 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.4 | 3.4 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 1.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) IkappaB kinase activity(GO:0008384) |
0.4 | 2.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 4.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.4 | 3.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 5.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 5.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 2.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.3 | 2.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 4.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 3.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 1.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 3.7 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.3 | 12.1 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.3 | 0.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) diacylglycerol O-acyltransferase activity(GO:0004144) |
0.3 | 2.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 3.0 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.3 | 2.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.1 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
0.3 | 1.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 1.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 1.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 2.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 2.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.3 | 3.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 5.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 2.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 1.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 1.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 26.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 2.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 3.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 4.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 4.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 11.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 5.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 7.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 5.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 2.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 1.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 1.0 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
0.2 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 4.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 1.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 2.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 1.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 1.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 2.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 1.0 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.2 | 69.7 | GO:0005549 | odorant binding(GO:0005549) |
0.2 | 3.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.9 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.2 | 0.5 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.6 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 2.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 1.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 5.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.3 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 2.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.2 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 1.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 78.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.2 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 0.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 2.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 1.4 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.2 | GO:0015923 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.0 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 1.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 2.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 137.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.5 | 593.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
2.3 | 122.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.8 | 20.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.3 | 48.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.9 | 39.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.8 | 14.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.7 | 2.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.6 | 10.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.6 | 0.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.6 | 11.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 20.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.5 | 14.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.5 | 2.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 16.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 9.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 2.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 20.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 12.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 15.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 16.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 5.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 5.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 9.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 14.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 13.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 1.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 6.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.3 | 7.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 11.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 12.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 2.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 1.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 7.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 13.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 3.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.5 | 296.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
12.5 | 200.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
9.5 | 28.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
8.5 | 127.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
8.5 | 110.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
8.2 | 156.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
8.1 | 169.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
7.7 | 23.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
5.1 | 45.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
4.9 | 39.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
4.7 | 61.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
4.7 | 28.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
4.4 | 127.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
4.2 | 38.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
3.7 | 98.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
3.6 | 29.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
3.0 | 27.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.9 | 52.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
2.9 | 34.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
2.8 | 16.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.6 | 37.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
2.2 | 367.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
2.2 | 64.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
2.1 | 45.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
2.0 | 12.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
2.0 | 48.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
1.8 | 29.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
1.8 | 35.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.6 | 38.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.5 | 25.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.5 | 41.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.4 | 15.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.3 | 22.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.3 | 18.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.1 | 13.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.1 | 46.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
1.1 | 8.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.1 | 22.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
1.1 | 80.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.1 | 20.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.0 | 14.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.0 | 33.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.0 | 5.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.0 | 10.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.9 | 15.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.9 | 8.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.9 | 19.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.8 | 17.2 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.8 | 23.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.8 | 15.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.8 | 9.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.8 | 26.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.7 | 1.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.7 | 17.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.7 | 83.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.7 | 7.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.7 | 15.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.6 | 4.9 | REACTOME OPSINS | Genes involved in Opsins |
0.6 | 6.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.6 | 7.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.5 | 19.5 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.5 | 1.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.5 | 6.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.5 | 5.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.5 | 8.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 8.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.5 | 6.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 2.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.4 | 24.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 1.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 5.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 6.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 2.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 2.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 2.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 2.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 6.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 3.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 6.0 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 1.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 15.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 3.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 6.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 5.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 4.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 4.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 3.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 4.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 5.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 3.2 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 3.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 2.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 2.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 1.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.2 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 0.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 1.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 1.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |